Safety of switching directly from lamivudine to adefovir, versus overlapping lamivudine and adefovir followed by adefovir monotherapy, in patients with chronic hepatitis B.
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2011
At a glance
- Drugs Adefovir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 10 Feb 2011 New trial record